ATE418324T1 - Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen - Google Patents

Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen

Info

Publication number: ATE418324T1
Authority: AT; Austria
Prior art keywords: medical devices; dosage forms; pharmaceutical dosage; formulation containing; mucoadhesive
Prior art date: 2005-06-06

Application number

AT06754047T

Other languages

English (en)

Inventor

Giuseppe Bottoni

Paola Maffei

Annalisa Sforzini

Mascia Federici

Carla Caramella

Silvia Rossi

Giuseppe Viscomi

Original Assignee

Alfa Wassermann Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-06

Filing date

2006-06-01

Publication date

2009-01-15

2006-06-01 Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa

2009-01-15 Application granted granted Critical

2009-01-15 Publication of ATE418324T1 publication Critical patent/ATE418324T1/de

Links

238000009472 formulation Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
230000003232 mucoadhesive effect Effects 0.000 title abstract 3
229920002000 Xyloglucan Polymers 0.000 title abstract 2
239000002552 dosage form Substances 0.000 title 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
210000004400 mucous membrane Anatomy 0.000 abstract 3
238000013270 controlled release Methods 0.000 abstract 2
239000004902 Softening Agent Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
230000003020 moisturizing effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Otolaryngology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Pulmonology (AREA)
Dispersion Chemistry (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Tropical Medicine & Parasitology (AREA)
Rheumatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Virology (AREA)

AT06754047T 2005-06-06 2006-06-01 Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen ATE418324T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000388A ITBO20050388A1 (it)	2005-06-06	2005-06-06	Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche

Publications (1)

Publication Number	Publication Date
ATE418324T1 true ATE418324T1 (de)	2009-01-15

Family

ID=36954507

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06754047T ATE418324T1 (de)	2005-06-06	2006-06-01	Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen

Country Status (22)

Country	Link
US (3)	US20090081133A1 (de)
EP (1)	EP1898876B1 (de)
JP (1)	JP5118633B2 (de)
KR (1)	KR101337578B1 (de)
CN (2)	CN102079794B (de)
AT (1)	ATE418324T1 (de)
BR (1)	BRPI0611400B8 (de)
CA (1)	CA2604768C (de)
CY (1)	CY1108875T1 (de)
DE (1)	DE602006004451D1 (de)
DK (1)	DK1898876T3 (de)
ES (1)	ES2318756T3 (de)
IL (1)	IL186655A (de)
IT (1)	ITBO20050388A1 (de)
MX (1)	MX2007015074A (de)
NO (1)	NO338991B1 (de)
PL (1)	PL1898876T3 (de)
PT (1)	PT1898876E (de)
RU (1)	RU2403012C2 (de)
SI (1)	SI1898876T1 (de)
UA (1)	UA90507C2 (de)
WO (1)	WO2006131262A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1698630E (pt)	2005-03-03	2014-09-15	Alfa Wassermann Spa	Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
US20090068122A1 (en) *	2007-09-06	2009-03-12	Shira Pilch	Dentifrice Compositions for Treating Xerostomia
CA2720755A1 (en) *	2008-04-11	2009-10-15	Sembiosys Genetics, Inc.	Controlled release of active agents from oleosomes
WO2010088191A1 (en) *	2009-01-27	2010-08-05	Teleflex Medical Incorporated	Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
JP2011001317A (ja) *	2009-06-19	2011-01-06	Fumakilla Ltd	鼻用洗浄剤
IT1397132B1 (it) *	2009-12-01	2013-01-04	Alfa Wassermann Spa	Composizioni comprendenti antiinfiammatori non steroidei.
SG185693A1 (en)	2010-05-24	2012-12-28	Indena Spa	Tamarind seed polysaccharide for use in the treatment of microbial infections
SI2575973T1 (sl)	2010-05-24	2017-10-30	Indena S.P.A.	Polisaharid semen tamarinde in ekstrakt iz ferula hermonis, za uporabo pri zdravljenju vnetnih bolezni
WO2012033634A2 (en)	2010-09-09	2012-03-15	Mary Kay Inc.	Topical skin care formulations comprising plant extracts
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US8633178B2 (en)	2011-11-23	2014-01-21	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US9091622B2 (en)	2011-12-20	2015-07-28	Exxonmobil Upstream Research Company	Capillary-based calibration standards for measurement of permeability
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
CA2870170C (en)	2012-09-12	2018-06-12	Boston Scientific Scimed, Inc.	Adhesive stent coating for anti-migration
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20150094266A1 (en) *	2013-06-11	2015-04-02	Novintethical Pharma, SA	Xyloglucan and protein compositions for the treatment of intestinal disorders
ITMI20130960A1 (it) *	2013-06-11	2014-12-12	Novintethical Pharma Sagl	Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
ITMI20132103A1 (it) *	2013-12-16	2015-06-17	Novintethical Pharma Sagl	Composizioni topiche nasali contenenti xiloglucani per uso come decongestionanti
CA2945631C (en)	2014-04-15	2023-04-11	Novintethical Pharma Sa	Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
EP3145489A1 (de)	2014-05-22	2017-03-29	TherapeuticsMD, Inc.	Natürliche kombinierte hormonersatzformulierungen und therapien
RU2016141135A (ru)	2014-07-29	2018-08-28	Терапьютиксмд, Инк.	Трансдермальный крем
US11623008B2 (en) *	2014-08-20	2023-04-11	Professional Compounding Centers Of America	Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (de)	2015-06-11	2018-11-14	Novintethical Pharma SA	Topische nasale zusammensetzungen mit xyloglucanen zur verwendung als abschwellendes mittel
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
WO2017173044A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd Inc.	Steroid hormone compositions in medium chain oils
WO2017173071A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
EP3463418B1 (de)	2016-05-31	2025-07-09	Devintec Sagl	Pharmazeutische zusammensetzungen zur behandlung von darmbeschwerden
KR20190026686A (ko) *	2016-07-08	2019-03-13	아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이	벤지다민을 포함하는 약학적 조성물
IT201700108526A1 (it) *	2017-09-28	2019-03-28	Alfasigma Spa	Composizioni orali per il trattamento del refluso gastroesofageo.
ES3060710T3 (en) *	2019-06-21	2026-03-27	Alfasigma Spa	Pharmaceutical compositions in the form of gel containing xyloglucan and alcohols for the controlled release of active ingredients
IT202100010802A1 (it)	2021-05-03	2022-11-03	Alfasigma Spa	Formulazione solida mucoadesiva comprendente probiotici per uso nella prevenzione e nel trattamento di disbiosi orale.
JP7851113B2 (ja) *	2021-12-08	2026-04-24	Ｍｐ五協フード＆ケミカル株式会社	噴霧用組成物
CN114306237A (zh) *	2022-01-06	2022-04-12	江苏爱朋医疗科技股份有限公司	一种鼻腔护理喷雾剂及其制备方法和应用
WO2026078513A1 (en)	2024-10-07	2026-04-16	Labomar S.P.A.	Formulation comprising a mucoadhesive, washout-resistant and film- forming association

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2059300T3 (es) *	1989-10-31	1994-12-01	Columbia Lab Inc	Metodo de humidificacion de tejidos y composicion.
JPH07289179A (ja) *	1994-04-28	1995-11-07	Dainippon Pharmaceut Co Ltd	米飯用改質剤
US6271001B1 (en) *	1995-03-23	2001-08-07	Bio Polymers Pty. Ltd.	Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
JP3909095B2 (ja) *	1995-04-11	2007-04-25	大日本住友製薬株式会社	可逆的熱ゲル化剤
IT1283911B1 (it) *	1996-02-05	1998-05-07	Farmigea Spa	Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
JP4259613B2 (ja) *	1996-02-13	2009-04-30	大日本住友製薬株式会社	ガラクトキシログルカンを用いるドラッグ・デリバリー・システム
JPH11152207A (ja) *	1997-11-20	1999-06-08	Shiseido Co Ltd	化粧料
JPH10259142A (ja) *	1997-03-14	1998-09-29	Shiseido Co Ltd	化粧料
EP1021204B1 (de) *	1997-09-26	2005-12-28	Noven Pharmaceuticals, Inc.	Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DK1383512T3 (da) *	2001-05-03	2004-11-15	Farmigea Spa	Anvendelse af sucralfat til behandling af cervikal erosion
DE10344126A1 (de) *	2003-09-24	2005-04-21	Henkel Kgaa	Wasserlöslicher Schmelzklebstoff
US20050214230A1 (en) *	2004-03-23	2005-09-29	J. B. Chemicals & Pharmaceuticals Ltd.	Novel stomatological gel

2005
- 2005-06-06 IT IT000388A patent/ITBO20050388A1/it unknown
2006
- 2006-01-06 UA UAA200711344A patent/UA90507C2/uk unknown
- 2006-06-01 AT AT06754047T patent/ATE418324T1/de active
- 2006-06-01 RU RU2007143998/15A patent/RU2403012C2/ru active
- 2006-06-01 WO PCT/EP2006/005240 patent/WO2006131262A1/en not_active Ceased
- 2006-06-01 SI SI200630188T patent/SI1898876T1/sl unknown
- 2006-06-01 KR KR1020077028142A patent/KR101337578B1/ko not_active Expired - Fee Related
- 2006-06-01 PT PT06754047T patent/PT1898876E/pt unknown
- 2006-06-01 MX MX2007015074A patent/MX2007015074A/es active IP Right Grant
- 2006-06-01 EP EP06754047A patent/EP1898876B1/de active Active
- 2006-06-01 CN CN2010105570198A patent/CN102079794B/zh active Active
- 2006-06-01 JP JP2008514019A patent/JP5118633B2/ja active Active
- 2006-06-01 PL PL06754047T patent/PL1898876T3/pl unknown
- 2006-06-01 US US11/921,286 patent/US20090081133A1/en not_active Abandoned
- 2006-06-01 DE DE602006004451T patent/DE602006004451D1/de active Active
- 2006-06-01 CN CN2006800176445A patent/CN101180036B/zh active Active
- 2006-06-01 DK DK06754047T patent/DK1898876T3/da active
- 2006-06-01 BR BRPI0611400A patent/BRPI0611400B8/pt not_active IP Right Cessation
- 2006-06-01 ES ES06754047T patent/ES2318756T3/es active Active
- 2006-06-01 CA CA2604768A patent/CA2604768C/en active Active
2007
- 2007-10-15 IL IL186655A patent/IL186655A/en active IP Right Grant
- 2007-11-26 NO NO20076083A patent/NO338991B1/no not_active IP Right Cessation
2009
- 2009-03-12 CY CY20091100281T patent/CY1108875T1/el unknown
2011
- 2011-10-19 US US13/277,130 patent/US20120088726A1/en not_active Abandoned
2013
- 2013-01-23 US US13/747,889 patent/US20130183325A1/en not_active Abandoned

Also Published As

Publication number	Publication date
UA90507C2 (uk)	2010-05-11
CN102079794A (zh)	2011-06-01
KR101337578B1 (ko)	2013-12-09
BRPI0611400A8 (pt)	2017-12-26
ITBO20050388A1 (it)	2006-12-07
CN102079794B (zh)	2012-03-28
US20130183325A1 (en)	2013-07-18
CA2604768C (en)	2013-07-30
CA2604768A1 (en)	2006-12-14
US20090081133A1 (en)	2009-03-26
SI1898876T1 (sl)	2009-04-30
MX2007015074A (es)	2008-01-24
ES2318756T3 (es)	2009-05-01
EP1898876A1 (de)	2008-03-19
NO20076083L (no)	2007-11-26
WO2006131262A1 (en)	2006-12-14
CN101180036A (zh)	2008-05-14
DK1898876T3 (da)	2009-03-02
PT1898876E (pt)	2009-03-05
IL186655A0 (en)	2008-01-20
IL186655A (en)	2010-12-30
JP5118633B2 (ja)	2013-01-16
US20120088726A1 (en)	2012-04-12
CY1108875T1 (el)	2014-07-02
NO338991B1 (no)	2016-11-07
DE602006004451D1 (de)	2009-02-05
JP2008542324A (ja)	2008-11-27
PL1898876T3 (pl)	2009-06-30
KR20080016596A (ko)	2008-02-21
CN101180036B (zh)	2011-07-27
RU2007143998A (ru)	2009-07-20
BRPI0611400A2 (pt)	2010-09-08
RU2403012C2 (ru)	2010-11-10
EP1898876B1 (de)	2008-12-24
BRPI0611400B8 (pt)	2021-05-25
BRPI0611400B1 (pt)	2020-04-28

Legal Events

Date

Code

Title

Description

2009-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1898876

Country of ref document: EP

Publication	Publication Date	Title
ATE418324T1 (de)	2009-01-15	Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
DE69906518D1 (de)	2003-05-08	Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
NO20071354L (no)	2007-05-29	anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
NO20080284L (no)	2008-03-07	Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
DE602006014990D1 (de)	2010-07-29	Intranasale verabreichung von schnell wirkendem insulin
DE60120648D1 (de)	2006-07-27	Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
HRP20030046B1 (hr)	2011-08-31	Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom
PT1256340E (pt)	2003-12-31	Sistema terapeutico transdermico aperfeicoado para o tratamento da doenca de parkinson
EA200700049A1 (ru)	2007-04-27	Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
CY1107452T1 (el)	2012-12-19	Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
ATE332138T1 (de)	2006-07-15	Flibanserin zur behandlung extrapyramidaler bewegungsstörungen
PT1383752E (pt)	2005-11-30	3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
BRPI0408655A (pt)	2006-03-28	formulações compreendendo um agente ativo e cacau em pó e a sua utilização
NZ605469A (en)	2015-01-30	Nalbuphine-based formulations and uses thereof
ITMI20030195A1 (it)	2004-08-07	Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
ECSP066608A (es)	2006-10-25	Suspensiones acuosas de ciclesonide para nebulización
AR044200A1 (es)	2005-09-07	Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
PT1425005E (pt)	2006-09-29	Composicao farmaceutica que compreende lumiracoxib
DK1608349T3 (da)	2008-02-18	Oralt tilförselssystem omfattende et antibakterielt og et antiinflammatorisk middel
BRPI0411702B8 (pt)	2021-05-25	uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
BR0116653A (pt)	2004-02-17	Medicamento contendo uma poliamina como substância ativa
ATE256134T1 (de)	2003-12-15	Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
BRPI0414223A (pt)	2006-10-31	uso de extratos de gentiana lutea como um agente antimicrobiano
Girdwood	1988	Infections associated with sport
UY27472A1 (es)	2003-05-30	Metodo para la preparación de una composición farmacéutica que comprende un acido-5-amino-salicilico, para uso en el tratamiento de la colitis ulcerosa y enfermedad de crohn.